<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K/A
[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
For fiscal year ended MARCH 31, 1996
---------------------------------
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from ---------------- to ----------------
Commission File Number 0-16594
MEDICAL TECHNOLOGY SYSTEMS, INC.
------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 59-2740462
- ---------------------------------- -----------------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
12920 AUTOMOBILE BOULEVARD, CLEARWATER, FLORIDA 34622
- ----------------------------------------------- -----
Registrant's telephone number, including area code (813) 576-6311
--------------
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Name of each exchange on which registered
------------------- -----------------------------------------
NONE NONE
---- ----
Securities registered pursuant to Section 12(g) of the Act:
COMMON STOCK, PAR VALUE $.01
----------------------------
(Title of Class)
COMMON STOCK PURCHASE WARRANTS
-------------------------------
(Title of Class)
Indicate by check mark whether the registrant (1) has filed all required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934
during the preceding 12 months (or of such shorter period that the registrant
was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes X No
--- ---
Indicate by check mark if disclosure of delinquent filers pursuant to
Item 405 of Regulation S-K is not contained herein, and will not be
contained, to the best of registrant's knowledge, in definitive proxy or
information statements incorporated by reference in Part III of this Form
10-K or any amendment to this Form 10-K.
Aggregate market value of voting common stock held by non-affiliates was
$3,700,000 at July 1, 1996.
The number of shares outstanding of the registrant's common stock, $.01
par value, was 5,444,335 at July 1, 1996.
DOCUMENTS INCORPORATED BY REFERENCE
-----------------------------------
Location in Form 10-K Incorporated Document
- --------------------- ----------------------------------------------
Part III Registrant's definite proxy statement for 1996
annual meeting of shareholders.
Total number of pages, including cover page - 42 (excluding the exhibits)
<PAGE>
SIGNATURES
Pursuant to the requirements Section 13 or 15(d) of the Securities
Exchange Act of 1934 the registrant has duly caused this Form 10-K to be
signed on its behalf by the undersigned, thereunto duly authorized.
MEDICAL TECHNOLOGY SYSTEMS, INC.
August 27, 1996 By: /s/ Todd E. Siegel
-----------------------------------------
Todd E. Siegel (Chief Executive Officer)
Pursuant to the requirements of the Securities Exchange Act of 1934,
this report has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated.
SIGNATURE TITLE DATE
--------- ----- ----
/s/ Todd E. Siegel Executive Officer, President August 27, 1996
- -------------------------- (Principal Executive Officer)
Todd E. Siegel Treasurer (Principal Financial
Officer and Director
/s/ R. Rhodes Principal Accounting Officer, August 27, 1996
- -------------------------- Controller
R. Rhodes
/s/ Gerald R. Couture Director August 27, 1996
- --------------------------
Gerald R. Couture
41
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE AUDITED
FINANCIAL STATEMENTS FOR MEDICAL TECHNOLOGY SYSTEMS INC. FOR THE YEAR ENDED
MARCH 31, 1996 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> YEAR
<FISCAL-YEAR-END> MAR-31-1996
<PERIOD-START> APR-01-1995
<PERIOD-END> MAR-31-1996
<CASH> 965
<SECURITIES> 0
<RECEIVABLES> 3788
<ALLOWANCES> 528
<INVENTORY> 2445
<CURRENT-ASSETS> 7814
<PP&E> 8079
<DEPRECIATION> 3162
<TOTAL-ASSETS> 14669
<CURRENT-LIABILITIES> 2408
<BONDS> 0
0
1
<COMMON> 55
<OTHER-SE> 8320
<TOTAL-LIABILITY-AND-EQUITY> 14669
<SALES> 17052
<TOTAL-REVENUES> 17052
<CGS> 10665
<TOTAL-COSTS> 41669
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 1739
<INCOME-PRETAX> (24617)
<INCOME-TAX> (1900)
<INCOME-CONTINUING> (22717)
<DISCONTINUED> (11863)
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (34580)
<EPS-PRIMARY> (8.52)
<EPS-DILUTED> (8.52)
</TABLE>
